Now in its third year, this event is more important than ever for the Pharmaceutical and Biotech industry, intent on “de-risking” drug development by incorporating the use of tissues in the drug discovery process. Learn what methods can help improve your prediction of clinical methods - -Random Homozygous Knockout (RHKO), RNAi, Histological Methods and more…Hear industry case studies from AstraZeneca and Aventis on the use of human tissues in comparison with animal models for target validation. What are the pros and cons? Don’t miss this significant meeting and the opportunity for exciting interactive networking with your peers who are using Human Tissues for Drug Discovery through Preclinical Research. For up-to-date information and to register, visit www.LifeSciencesInfo.com/tissues.